[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2425857A1 - Agents antimitotiques renfermant une cyanine - Google Patents

Agents antimitotiques renfermant une cyanine

Info

Publication number
FR2425857A1
FR2425857A1 FR7912486A FR7912486A FR2425857A1 FR 2425857 A1 FR2425857 A1 FR 2425857A1 FR 7912486 A FR7912486 A FR 7912486A FR 7912486 A FR7912486 A FR 7912486A FR 2425857 A1 FR2425857 A1 FR 2425857A1
Authority
FR
France
Prior art keywords
cyanine
agents containing
antimitotic agents
antimitotic
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7912486A
Other languages
English (en)
Other versions
FR2425857B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5927478A external-priority patent/JPS54151133A/ja
Priority claimed from JP10354978A external-priority patent/JPS5531024A/ja
Priority claimed from JP14385878A external-priority patent/JPS5569513A/ja
Priority claimed from JP854479A external-priority patent/JPS55100318A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2425857A1 publication Critical patent/FR2425857A1/fr
Application granted granted Critical
Publication of FR2425857B1 publication Critical patent/FR2425857B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Agents antimitotiques renfermant une cyanine. Ce composé antimitotique est une cyanine ayant la formule :
FR7912486A 1978-05-17 1979-05-16 Agents antimitotiques renfermant une cyanine Granted FR2425857A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5927478A JPS54151133A (en) 1978-05-17 1978-05-17 Antitumorigenic agent
JP10354978A JPS5531024A (en) 1978-08-24 1978-08-24 Anti-tumor agent
JP14385878A JPS5569513A (en) 1978-11-20 1978-11-20 Anti-tumor agent
JP854479A JPS55100318A (en) 1979-01-26 1979-01-26 Antitumorigenic agent

Publications (2)

Publication Number Publication Date
FR2425857A1 true FR2425857A1 (fr) 1979-12-14
FR2425857B1 FR2425857B1 (fr) 1982-12-03

Family

ID=27454964

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7912486A Granted FR2425857A1 (fr) 1978-05-17 1979-05-16 Agents antimitotiques renfermant une cyanine

Country Status (3)

Country Link
DE (1) DE2919447A1 (fr)
FR (1) FR2425857A1 (fr)
GB (1) GB2020975B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464383A (en) * 1981-11-24 1984-08-07 Itaru Yamamoto Immunomodulator containing trithiazole pentamethine cyanine derivative
EP0198605A1 (fr) * 1985-03-19 1986-10-22 Teijin Limited Prophylaxie de la pharmacothérapie des affections hépatiques
AU1144688A (en) * 1987-03-17 1988-09-15 Dana-Farber Cancer Institute, Inc. A pharmaceutical composition comprising cyanine dye
JP2824917B2 (ja) * 1989-08-30 1998-11-18 株式会社林原生物化学研究所 抗腫瘍剤
NO923126L (no) * 1991-08-13 1993-02-15 Fuji Photo Film Co Ltd Preparat og metode for behandling av canser
WO1996003393A1 (fr) * 1994-07-21 1996-02-08 Fuji Photo Film Co., Ltd. Compose de methine soluble dans l'eau et composition pharmaceutique utilisee dans le traitement du cancer contenant ce compose
DE19706161A1 (de) * 1997-02-17 1998-08-20 Oswald Hartmut Prof Dr Med Verwendung von Cyaninen, Isocyaninen und Pseudoisocyaninen als Diuretika
DE19841985A1 (de) * 1998-09-03 2000-03-09 Schering Ag Dialkylsulfonsäure- und Dialkylcarbonsäure-Derivate
US6190641B1 (en) * 2000-01-18 2001-02-20 Mallinckrodt Inc. Indocyanine dyes
US6761878B2 (en) * 2001-10-17 2004-07-13 Mallinckrodt, Inc. Pathological tissue detection and treatment employing targeted benzoindole optical agents
GB0603455D0 (en) * 2006-02-21 2006-04-05 Cancer Rec Tech Ltd Therapeutic compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2812261A1 (de) * 1977-03-25 1978-09-28 Ciba Geigy Ag Verfahren zur bekaempfung von mikroorganismen und neue phthalocyaninverbindungen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2812261A1 (de) * 1977-03-25 1978-09-28 Ciba Geigy Ag Verfahren zur bekaempfung von mikroorganismen und neue phthalocyaninverbindungen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1979 *
EXBK/47 *

Also Published As

Publication number Publication date
GB2020975B (en) 1983-03-30
GB2020975A (en) 1979-11-28
FR2425857B1 (fr) 1982-12-03
DE2919447A1 (de) 1979-11-22

Similar Documents

Publication Publication Date Title
DE3162445D1 (de) 3-aryloxy-3-phenylpropylamines
FR2453145A1 (fr)
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
FR2442849A1 (fr)
IT1083151B (it) Procedimento d'idrocianazione di composti organici insaturi comportanti almeno un doppio etilenico
IT7922251A0 (it) Composto di gomma fluorato.
FR2425857A1 (fr) Agents antimitotiques renfermant une cyanine
IT7921967A0 (it) Custodia per disposizione di semiconduttori.
FR2358141A1 (fr) Nouveaux anesthesiques locaux
FR2381746A1 (fr) Nouveaux derives encephaliniques a la methionine
FR2367761A1 (fr) Derives piperidylideniques de benzo-xanthenes,
FR2357558A1 (fr) 2,6-methano-2h-1-benzoxocines
BG32264A3 (en) Fungicide means
AT365313B (de) Bohrlochpumpenanordnung
DE3280311D1 (de) Fungizide alpha-azolylglykole.
FR2434161A1 (fr) Nouvel hexahydrobenzopyranne et sa preparation
KR850001663A (ko) 살충 및 응애류 박멸제 조성물
FR2416223A1 (fr) Derives de phenylpyrol utilisables comme fongicides
FR2426673A1 (fr) Pesticides du type pyrethrine
IT1102427B (it) Procedimento per la preparazione di un composto fungicida mediante reazione di alchilazione
FR2378519A1 (fr)
FR2435946A1 (fr) Agents diuretiques
FR2367766A1 (fr) Intermediaire pour la pre
FR2371447A1 (fr) Nouveaux b-lactames antibiotiques
IT7823872A0 (it) Composto fungicida.

Legal Events

Date Code Title Description
ST Notification of lapse